Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Molecular Drug Design
Computational Drug Design: Applications of AI and Machine Learning in Development
Recent advances in AI and machine learning have huge potential to improve the accuracy and speed of drug design. This discussion group report explores some of the current applications of different AI/ML approaches, including deep learning techniques.
Organ Modelling
Differentiation of embryonic and induced pluripotent stem cells
Pluripotent stem cells possess the capacity for indefinite self-renewal and the potential to differentiate into all adult cell types of the three primary germ layers.
Medicinal Chemistry
Automation Experts Discuss New Platform for Synthesis in Organic Chemistry
Our Discussion Group featured expert conversation on automation and synthesis from software to hardware, key challenges, and end goals.
Pharma Data
In Conversation With Dr. Maya Natarajan, Neo4J
In the lead up to our 2022 Pharma Data & SmartLabs Congress taking place this September, we sat down with Maya Natarajan, Senior Director Knowledge Graphs at Neo4j. Being a key player within the field, Maya gave us insights into the pioneering work Neo4j is doing with knowledge graphs and the types of graph analytics that Neo4J provides.
Discussion Group Report - Mobile Robotics
This November, our PharmaTec Series discussion group focused on mobile robotics. We explored their current uses, challenges and potential.
Target Discovery
Accelerating Target Discovery with Genomic and CRISPR Techniques
Benedict Cross, Chief Technology Officer at PhoreMost, leads our Discussion Group on Target-Based Drug Discovery using Genomic and CRISPR techniques.
Medicinal Chemistry
Mcule: Compound Sourcing Expert
Mcule is a leading chemical marketplace for drug discovery where you can order small-molecule samples from a high-quality database. We acquire the compounds from the manufacturers and deliver them in a consolidated package, in the format specified by you
Molecular Drug Design
The Highs and Lows of Applying AI to Drug Design
September's discussion group takes us through AI applied to drug design. Where it has been useful, and where it has been not so useful.
